Next Article in Journal
Can We Well Assess the Relative Efficacy and Tolerability of a New Drug Versus Others at the Time of Marketing Authorization Using Mixed Treatment Comparisons? A Detailed Illustration with Escitalopram
Previous Article in Journal
Cost Savings of Anti-TNF Therapy Using a Test-Based Strategy versus an Empirical Dose Escalation in Crohn's Disease Patients Who Lose Response to Infliximab
 
 

Order Article Reprints

Journal: J. Mark. Access Health Policy, 2015
Volume: 3
Number: 29321

Article: Reimbursement of Licensed Cell and Gene Therapies Across the Major European Healthcare Markets
Authors: by Jesper Jørgensen and Panos Kefalas
Link: https://www.mdpi.com/2001-6689/3/1/29321

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop